Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice

Daozhou Liu,Qifeng Ji,Ying Cheng,Miao Liu,Bangle Zhang,Qibing Mei,Menglei Huan,Siyuan Zhou
DOI: https://doi.org/10.1186/s12951-022-01474-x
IF: 10.2
2022-06-04
Journal of Nanobiotechnology
Abstract:Ischemic stroke is one of the main causes of death and disability in the world. The treatment for ischemic stroke is to restore blood perfusion as soon as possible. However, when ischemic brain tissue is re-perfused by blood, the mitochondrial permeability transition pore (mPTP) in neuron and microglia is excessively opened, resulting in the apoptosis of neuron and nerve inflammation. This aggravates nerve injury. Cyclosporine A (CsA) inhibits the over-opening of mPTP, subsequently reducing the release of ROS and the apoptosis of cerebral ischemia/reperfusion injured neuron and microglia. However, CsA is insoluble in water and present in high concentrations in lymphatic tissue. Herein, cerebral infarction tissue targeted nanoparticle (CsA@HFn) was developed to treat cerebral ischemia/reperfusion injury.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?